Week 1 Quiz | 100% Correct | 2026/2027 Academic Year
Part A: Core Pharmacologic Principles & Terminology (4 Questions)
Q1. The study of how a drug is absorbed, distributed, metabolized, and excreted by the
body is known as:
A. Pharmacotherapeutics
B. Pharmacodynamics
C. Pharmacokinetics [CORRECT]
D. Pharmacogenomics
Correct Answer: C
Rationale: Pharmacokinetics (PK) is defined as "what the body does to the drug" and
encompasses the four processes of Absorption, Distribution, Metabolism, and Excretion
(ADME). Pharmacodynamics (B) is "what the drug does to the body" (mechanism of
action, receptor interactions). Pharmacotherapeutics (A) refers to the clinical
application of drugs to treat disease states. Pharmacogenomics (D) is the study of how
genetic variations influence individual drug responses—a growing field in personalized
medicine for 2026/2027.
Q2. The proprietary name given to a drug by its manufacturer is the:
A. Chemical name
B. Generic name
C. Trade (Brand) name [CORRECT]
D. Official name
Correct Answer: C
Rationale: The Trade or Brand name is the proprietary, trademarked name assigned by
the pharmaceutical manufacturer for marketing purposes (e.g., Lipitor®, Tylenol®). The
Generic name (B) is the non-proprietary, universally accepted United States Adopted
, Name (USAN) (e.g., atorvastatin, acetaminophen). The Chemical name (A) describes
the precise molecular structure using IUPAC nomenclature. The Official name (D) is
typically identical to the generic name as listed in the United States Pharmacopeia
(USP).
Q3. Pharmacogenomics is best defined as:
A. The study of how drugs interact with specific genetic mutations to alter drug
response [CORRECT]
B. The study of drug absorption in different ethnic populations
C. The branch of pharmacology concerned with drug synthesis
D. The study of toxic drug effects on genetic material
Correct Answer: A
Rationale: Pharmacogenomics examines how an individual's genetic makeup (genome)
affects their response to drugs, including efficacy, toxicity, and dosing requirements.
Examples include CYP2C19 polymorphisms affecting clopidogrel metabolism and
HLA-B*5701 screening before abacavir prescribing. This precision medicine approach is
increasingly emphasized in 2026/2027 clinical practice to individualize therapy and
reduce adverse drug events. Option B describes pharmacogenetics' broader population
applications; C is medicinal chemistry; D is genotoxicology.
Q4. Which source provides the most authoritative, evidence-based information on drug
dosing, interactions, and safety for U.S. prescribers?
A. Pharmaceutical sales representatives
B. Internet patient forums
C. Lexicomp or Micromedex clinical decision support databases [CORRECT]
D. Peer-reviewed primary literature only
Correct Answer: C
Rationale: Clinical decision support databases (Lexicomp, Micromedex, UpToDate,
Clinical Pharmacology) provide comprehensive, continuously updated, peer-reviewed
drug information including: dosing (adult/pediatric/renal/hepatic adjustments),